Skip to main content
. 2022 May 18;12:844527. doi: 10.3389/fonc.2022.844527

Table 2.

Detailed patient number and the mutational frequency.

primary (n=64) metastasis (n=54) Total P-value
SMAD4 10 (15.6%) 17 (31.5%) 27 (22.9%) 0.049
MTAP 1 (1.6%) 7 (13.0%) 8 (6.8%) 0.023
CDKN2B 0 (0%) 8 (14.8%) 8 (6.8%) 0.001
FAT3 0 (0%) 4 (7.4%) 4 (3.4%) 0.041